New guidelines regarding medications for gastrointestinal bleeding were jointly released by the American College of Gastroenterology and the Canadian Association of Gastroenterology on March 21.
Rinvoq (upadacitinib) has been approved by the FDA to treat adults with moderately to severely active ulcerative colitis who have had a poor response or intolerance to one or more tumor necrosis factor blockers.
Ben Bradenham Jr., MD, a gastroenterologist at Gastrointestinal Specialists in Richmond, Va., joined Becker’s to discuss how physician education is failing in attempts to counter burnout.
The Medical College of Georgia in Augusta is now offering a noninvasive screening for esophageal cancer with a new device, local ABC affiliate WJBF reported March 16.